Jiang P, Dickson D
Acta Neuropathol Commun. 2025; 13(1):53.
PMID: 40057802
PMC: 11889819.
DOI: 10.1186/s40478-025-01969-2.
Katel S, Cicalo J, Vasciaveo V, Carrion J, Leann M, Huerta P
bioRxiv. 2025; .
PMID: 40027607
PMC: 11870445.
DOI: 10.1101/2025.02.13.638144.
Galli S, Di Antonio M
Elife. 2025; 14.
PMID: 40019353
PMC: 11870650.
DOI: 10.7554/eLife.106119.
Yakoub Y, Gonzalez-Ortiz F, Ashton N, Dery C, Strikwerda-Brown C, St-Onge F
Alzheimers Dement. 2025; 21(2):e14537.
PMID: 40008832
PMC: 11863240.
DOI: 10.1002/alz.14537.
Kallweit L, Hamlett E, Saternos H, Gilmore A, Granholm A, Horowitz S
Elife. 2025; 14.
PMID: 39992714
PMC: 11850002.
DOI: 10.7554/eLife.105446.
Defining familiarity in nursing homes providing care for residents with dementia: a scoping review.
Sun J, Brennan S, Doan T
Front Dement. 2025; 4:1470066.
PMID: 39963504
PMC: 11830659.
DOI: 10.3389/frdem.2025.1470066.
Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E ε4.
Kim S, Keum M, Choe Y, Suh G, Lee B, Kim H
Nutrients. 2025; 17(3).
PMID: 39940451
PMC: 11819958.
DOI: 10.3390/nu17030595.
B-Lightning: using bait genes for marker gene hunting in single-cell data with complex heterogeneity.
Shao Y, Gao Q, Wang L, Li D, Nixon A, Chan C
Brief Bioinform. 2025; 26(1).
PMID: 39927857
PMC: 11808808.
DOI: 10.1093/bib/bbaf033.
The impact of apolipoprotein E, type ∊4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis.
Wan Z, Ma T
PLoS One. 2025; 20(2):e0303486.
PMID: 39913635
PMC: 11801730.
DOI: 10.1371/journal.pone.0303486.
Evaluating conversion from mild cognitive impairment to Alzheimer's disease with structural MRI: a machine learning study.
Vecchio D, Piras F, Natalizi F, Banaj N, Pellicano C, Piras F
Brain Commun. 2025; 7(1):fcaf027.
PMID: 39886067
PMC: 11780885.
DOI: 10.1093/braincomms/fcaf027.
A multi-cohort study of longitudinal and cross-sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults.
Xie L, Das S, Li Y, Wisse L, McGrew E, Lyu X
Alzheimers Dement. 2025; 21(2):e14492.
PMID: 39868491
PMC: 11848397.
DOI: 10.1002/alz.14492.
Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer's disease.
Kollarik S, Bimbiryte D, Sethi A, Dias I, Moreira C, Noain D
Front Aging Neurosci. 2025; 16():1519225.
PMID: 39831085
PMC: 11739298.
DOI: 10.3389/fnagi.2024.1519225.
Cognitive aging outcomes are related to both tau pathology and maintenance of cingulate cortex structure.
Pezzoli S, Giorgio J, Chen X, Ward T, Harrison T, Jagust W
Alzheimers Dement. 2025; 21(2):e14515.
PMID: 39807642
PMC: 11848174.
DOI: 10.1002/alz.14515.
Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer's Disease: An Observational Case-Control Study.
Bello-Corral L, Seco-Calvo J, Molina Fresno A, Gonzalez A, Llorente A, Fernandez-Lazaro D
Medicina (Kaunas). 2025; 60(12.
PMID: 39768823
PMC: 11679489.
DOI: 10.3390/medicina60121941.
Cortical and behavioral correlates of alexia in primary progressive aphasia and Alzheimer's disease.
Meyer A, Snider S, Faria A, Tippett D, Saloma R, Turkeltaub P
Neuropsychologia. 2025; 207:109066.
PMID: 39756511
PMC: 11847496.
DOI: 10.1016/j.neuropsychologia.2025.109066.
Comprehensive characterization of the transcriptional landscape in Alzheimer's disease (AD) brains.
Chen C, Zhang Z, Liu Y, Hong W, Karahan H, Wang J
Sci Adv. 2025; 11(1):eadn1927.
PMID: 39752483
PMC: 11698078.
DOI: 10.1126/sciadv.adn1927.
Complex genetic interactions affect susceptibility to Alzheimer's disease risk in the BIN1 and MS4A6A loci.
Nazarian A, Morado M, Kulminski A
Geroscience. 2025; .
PMID: 39751715
DOI: 10.1007/s11357-024-01477-6.
The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in ε4 non-carriers with mild cognitive impairment due to Alzheimer's disease.
Bakker A, Rani N, Mohs R, Gallagher M
Alzheimers Dement (N Y). 2025; 10(4):e70004.
PMID: 39748842
PMC: 11694516.
DOI: 10.1002/trc2.70004.
SUMO2 rescues neuronal and glial cells from the toxicity of P301L Tau mutant.
Orsini F, Pascente R, Martucci A, Palacino S, Fraser P, Arancio O
Front Cell Neurosci. 2024; 18:1437995.
PMID: 39726633
PMC: 11669524.
DOI: 10.3389/fncel.2024.1437995.
SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction.
Wang F, Han H, Wang C, Wang J, Peng Y, Chen Y
Transl Neurodegener. 2024; 13(1):68.
PMID: 39726060
PMC: 11674522.
DOI: 10.1186/s40035-024-00458-1.